SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.59 -539.35
( -0.70%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,058.92 -203.24
(-0.31%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

24.1923243

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

268.98

EPS(TTM)

Face Value()

Div & Yield %

Back

Trent consolidated net profit rises 20.79% in the June 2026 quarter

Aug 06,2026

Net profit of Trent rose 20.79% to Rs 519.01 crore in the quarter ended June 2026 as against Rs 429.69 crore during the previous quarter ended June 2025. Sales rose 17.84% to Rs 5754.71 crore in the quarter ended June 2026 as against Rs 4883.48 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5754.71	4883.48	18
OPM %	19.45	17.36	-
PBDT	1102.00	857.62	28
PBT	691.84	564.69	23
NP	519.01	429.69	21

76,933.59 -539.35 ( -0.70%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,058.92 -203.24 (-0.31%)

10,795.58 -82.54 (-0.76%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)